Workflow
Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis
IlluminaIllumina(US:ILMN) Prnewswire·2025-05-30 02:01

New AI algorithm accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome at scale for the first timeSAN DIEGO, May 29, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) today unveiled PromoterAI, a new AI algorithm that accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome. A study published today in Science illustrates how this deep learning technology discovered regulatory variants in noncoding "promoter" s ...